AstraZeneca has scope to increase dividend by 25%, key broker says, as broader FTSE 100 edges lower
January 08, 2021 at 09:00 AM EST
Anglo-Swedish pharmaceutical AstraZeneca has scope to increase its dividend by 25%, a key broker said on Friday.
